Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas
BACKGROUND: Lung adenocarcinomas can be distinguished by identifying mutated driver
oncogenes, including epidermal growth factor receptor (EGFR) and KRAS. Mutations in …
oncogenes, including epidermal growth factor receptor (EGFR) and KRAS. Mutations in …
[HTML][HTML] Association of KRAS and EGFR Mutations with Survival in Patients with Advanced Lung Adenocarcinomas
ML Johnson, CS Sima, J Chaft, PK Paik, W Pao… - Cancer, 2013 - ncbi.nlm.nih.gov
Background Lung adenocarcinomas can be distinguished by identifying mutated driver
oncogenes including EGFR and KRAS. Mutations in EGFR are associated with both an …
oncogenes including EGFR and KRAS. Mutations in EGFR are associated with both an …
[引用][C] Association of KRAS and EGFR Mutations With Survival in Patients With Advanced Lung Adenocarcinomas
ML JOHNSON, CS SIMA, J CHAFT, PK PAIK, W PAO… - Cancer, 2013 - pascal-francis.inist.fr
Association of KRAS and EGFR Mutations With Survival in Patients With Advanced Lung
Adenocarcinomas CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
Adenocarcinomas CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
[引用][C] Association ofKRASandEGFRmutations with survival in patients with advanced lung adenocarcinomas
ML Johnson, CS Sima, J Chaft, PK Paik, W Pao… - Cancer, 2012 - cir.nii.ac.jp
Association of<i>KRAS</i>and<i>EGFR</i>mutations with survival in patients with
advanced lung adenocarcinomas | CiNii Research CiNii 国立情報学研究所 学術情報 …
advanced lung adenocarcinomas | CiNii Research CiNii 国立情報学研究所 学術情報 …
Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas
ML Johnson, CS Sima, J Chaft, PK Paik, W Pao… - Cancer, 2013 - pubmed.ncbi.nlm.nih.gov
Background Lung adenocarcinomas can be distinguished by identifying mutated driver
oncogenes, including epidermal growth factor receptor (EGFR) and KRAS. Mutations in …
oncogenes, including epidermal growth factor receptor (EGFR) and KRAS. Mutations in …
Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas.
ML Johnson, CS Sima, J Chaft, PK Paik, W Pao… - Cancer, 2012 - europepmc.org
Background Lung adenocarcinomas can be distinguished by identifying mutated driver
oncogenes, including epidermal growth factor receptor (EGFR) and KRAS. Mutations in …
oncogenes, including epidermal growth factor receptor (EGFR) and KRAS. Mutations in …
Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas
ML Johnson, CS Sima, J Chaft, PK Paik, W Pao… - Cancer, 2013 - infona.pl
BACKGROUND: Lung adenocarcinomas can be distinguished by identifying mutated driver
oncogenes, including epidermal growth factor receptor (EGFR) and KRAS. Mutations in …
oncogenes, including epidermal growth factor receptor (EGFR) and KRAS. Mutations in …
Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas.
ML Johnson, CS Sima, J Chaft, PK Paik, W Pao… - Cancer, 2012 - europepmc.org
Background Lung adenocarcinomas can be distinguished by identifying mutated driver
oncogenes, including epidermal growth factor receptor (EGFR) and KRAS. Mutations in …
oncogenes, including epidermal growth factor receptor (EGFR) and KRAS. Mutations in …